Physician

Robert M Dermarkarian, M.D.

According to 2025 Medicare claims, Robert Dermarkarian, M.D. (NPI: 1770675530) practices pulmonary disease in the Port St. Lucie, FL market, with the plurality of this provider's patient population coming from Martin, FL. This provider's primary affiliated billing organization is PULMONARY & INTERNAL MEDICINE ASSOCIATES INC (NPI: 1013009810; TIN: 59-1884842) and primary practice location at 34996-3341. Dermarkarian is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), participating under the MSSP model.

Dermarkarian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,798 traditional Medicare patients, billed 23,861 HCPCS/CPT codes, and received $1,098,696 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,326 prescription claims across 569 beneficiaries totaling $3,167,554 in drug costs, led by Ofev (Nintedanib Esylate). DME data shows 3,484 claims. Open Payments data shows 116 records totaling $29,071. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $445,198 to $1,098,696. Similarly, Part D prescription costs have risen steadily, from $2,027,214 to $3,167,554. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $158,153 and ending at $182,159.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,123	5,889	$445,198
2016	1,313	5,721	$413,719
2017	1,420	6,055	$417,401
2018	1,529	12,626	$706,539
2019	1,316	17,184	$702,920
2020	1,433	9,126	$500,324
2021	1,655	9,811	$558,950
2022	1,656	14,427	$747,402
2023	1,736	19,901	$959,685
2024	1,798	23,861	$1,098,696

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	493	5,691	$2,027,214
2016	466	5,521	$1,921,073
2017	431	4,554	$1,595,701
2018	480	4,339	$1,850,096
2019	497	4,130	$2,006,369
2020	496	3,741	$2,542,262
2021	553	3,790	$3,087,033
2022	559	3,622	$2,948,001
2023	585	3,401	$3,196,916
2024	569	3,326	$3,167,554

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	885	3,139	$254,137
2016	958	3,064	$194,323
2017	913	3,005	$132,764
2018	1,100	3,143	$224,245
2019	1,231	3,717	$297,023
2020	1,136	3,682	$283,976
2021	1,104	3,236	$249,604
2022	904	2,835	$231,237
2023	1,182	3,583	$305,303
2024	1,125	3,484	$256,535

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,407	3,008	$100
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	795	6,687	$50
94729	Test to examine how well the lungs exchange gases	724	751	$43
94727	Test to determine lung volumes using gas dilution or washout	724	751	$34
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	724	3,028	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ofev	Nintedanib Esylate	69	2,310	$1,026,938
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	511	27,540	$565,735
Opsumit	Macitentan	16	720	$308,233
Uptravi	Selexipag	15	448	$212,571
Tracleer	Bosentan	18	510	$210,019

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	61	$53,456
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	12	63	$47,161
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	38	282	$20,887
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	18	89	$14,370
A7031	Face mask interface, replacement for full face mask, each	N	59	144	$11,886

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	116	$29,071	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Robert M. Dermarkarian, M.D.?

Tedicare shows public-source Medicare data for Robert M. Dermarkarian, M.D. (NPI 1770675530), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Robert M. Dermarkarian, M.D. have ACO affiliation data?

Robert M. Dermarkarian, M.D. is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591).

What billing organization is linked to Robert M. Dermarkarian, M.D.?

Robert M. Dermarkarian, M.D. is linked to PULMONARY & INTERNAL MEDICINE ASSOCIATES INC (billing NPI 1013009810) in the available physician profile data.

Does Robert M. Dermarkarian, M.D. have Open Payments data?

Robert M. Dermarkarian, M.D. has 116 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.